A novel therapy for the most common form of lung cancer shows promise and seems to yield largely manageable side effects, according to new research that will be presented at the 49th Annual Meeting of the American Society of Clinical Oncology.

Promising New Therapy For Lung Cancer

Medical News Today 
I think if we learn how to use it appropriately, and manage the side effects effectively, it will be a good drug to have in our armamentarium." ... A phase 1 trial that was previously published showed that 33% of the patients with NSCLC responded to ...

http://www.medicalnewstoday.com/articles/261312.php


BY 
WORLD DRUG TRACKER
DR ANTHONY MELVIN CRASTO